The Clinical Trials register has listed a just completed trial for something cryptically called 0444 Gel. The Gel is targeted for the papules and pustules of rosacea. Apparently the study started in January 2008 and has just been completed.
Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea
Sponsor: Nycomed US Inc
The aim of this trial is to assess the efficacy of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea.
Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.
So what could this gel be ? As far as I can see, likely candidates include Solaraze as well as a new generic form of metrogel. These two classes of products are manufactured by companies related to or owned by Nycomed.
Solaraze
We learnt from a 2006 AAD Poster Session that Solaraze was being studied as a treatment for rosacea. SOLARAZE (diclofenac sodium-3%) Gel is indicated for the topical treatment of actinic keratoses (AKs).
SOLARAZE Gel is a registered trademarks of PharmaDerm, a Division of Nycomed US, Inc.
Solaraze is currently marketed in the US, Europe and Australia.
Generic Metrogel
Nycomed has a sister division Fougera Generics. A press release in 2005 alterted us to the fact that Fougera was poised to make generic metrogel 0.75%. Indeed you can find details on Fougera’s web site for Metronidazole Topical Lotion 0.75% (compares to MetroLotion) and Metronidazole Topical Cream 0.75% (compares to MetroCream).
Other Guesses
Any other guesses ? If you have more information about 0444 Gel please post in the comments below.
No comments yet ↓
There are no comments yet. Be the first by filling out the form below.
Leave a Comment